{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:42:19Z","timestamp":1777484539839,"version":"3.51.4"},"reference-count":41,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100008982","name":"Qatar National Research Fund","doi-asserted-by":"publisher","award":["NPRP12S-0219-190108"],"award-info":[{"award-number":["NPRP12S-0219-190108"]}],"id":[{"id":"10.13039\/100008982","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cancer Control"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>While delays in leukemia detection remain an ongoing challenge in hematologic cancer care, little is known about the factors associated with these delays. This article focuses on identifying the barriers hindering timely diagnosis of leukemia through a cohort analysis (2016-2021) of 220 Acute Myeloid Leukemia (AML), 161 Chronic Myeloid Leukemia (CML), 90 Acute Lymphocytic Leukemia (ALL), and 121 Chronic Lymphocytic Leukemia (CLL) patients in Qatar.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Of the 592 patients used for the study, subsets were identified and analyzed for delay (423), risk stratification (437), and leukemia stage (282).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There was an increasing trend in leukemia cases, with 32% of patients being diagnosed in the high-risk category. Out of 423 (median delay = 28\u00a0days) patients, 45% reported delayed diagnosis (median delay = 44 days). Further analysis of the association of delayed leukemia diagnosis using the univariate\n                      <jats:inline-formula>\n                        <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" overflow=\"scroll\">\n                          <mml:mrow>\n                            <mml:mi>\u03c7<\/mml:mi>\n                          <\/mml:mrow>\n                        <\/mml:math>\n                      <\/jats:inline-formula>\n                      2 independence test revealed significant associations to patient referral type, and the presence of certain comorbidities and symptoms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Significant delays in leukemia diagnosis were identified, though the exact cause remains unclear. These delays can be attributed to factors such as patient, primary care, referral, system, and physician delays. Therefore, further investigation is imperative for improving the detection, diagnosis, and referral processes in hematologic cancers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10732748241275026","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T13:12:39Z","timestamp":1743253959000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnosis Challenges in Adult Leukemia: Insights From a Single-Center Retrospective Study in Qatar (2016-2021)"],"prefix":"10.1177","volume":"32","author":[{"given":"Hesham A. B.","family":"Aboelkhir","sequence":"first","affiliation":[{"name":"Hamad Bin Khalifa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousra","family":"El Alaoui","sequence":"additional","affiliation":[{"name":"Hamad Bin Khalifa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Padmanabhan","sequence":"additional","affiliation":[{"name":"Hamad Bin Khalifa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majed","family":"Hadid","sequence":"additional","affiliation":[{"name":"Hamad Bin Khalifa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adel","family":"Elomri","sequence":"additional","affiliation":[{"name":"Hamad Bin Khalifa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanvir","family":"Alam","sequence":"additional","affiliation":[{"name":"Hamad Bin Khalifa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Amine","family":"Rejeb","sequence":"additional","affiliation":[{"name":"Hamad Medical Corporation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halima","family":"EL Omri","sequence":"additional","affiliation":[{"name":"Hamad Medical Corporation (HMC)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruba Y.","family":"Taha","sequence":"additional","affiliation":[{"name":"Hamad Medical Corporation (HMC)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesham","family":"Elsabah","sequence":"additional","affiliation":[{"name":"Hamad Medical Corporation (HMC)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4112-7924","authenticated-orcid":false,"given":"Abdelfatteh","family":"EL Omri","sequence":"additional","affiliation":[{"name":"Hamad Medical Corporation"},{"name":"Qatar University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"e_1_3_7_2_2","volume-title":"Global Cancer Observatory: Cancer Today","author":"Ferlay J","year":"2020","unstructured":"Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today. Lyon: International Agency for Research on Cancer; 2020. https:\/\/gco.iarc.fr\/today."},{"key":"e_1_3_7_3_2","unstructured":"WHO. Cancer Qatar 2020 country profile. 2020. https:\/\/cdn.who.int\/media\/docs\/default-source\/country-profiles\/cancer\/qat.pdf?sfvrsn=834f7d5c_2&download=true."},{"key":"e_1_3_7_4_2","article-title":"Mortality due to cancer treatment delay: systematic review and meta-analysis","volume":"371","author":"Hanna TP","year":"2020","unstructured":"Hanna TP, King WD, Thibodeau S, et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ. 2020;371:m4087.","journal-title":"BMJ"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.48"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.26719\/2010.16.2.166"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-020-04815-z"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2021.22.1.45"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-8-200710160-00010"},{"key":"e_1_3_7_10_2","unstructured":"UICC. Globocan 2020: new global cancer data | UICC. 2020. https:\/\/www.uicc.org\/news\/globocan-2020-new-global-cancer-data."},{"key":"e_1_3_7_11_2","unstructured":"UNICEF. Regional Classification. 2018. https:\/\/data.unicef.org\/wp-content\/uploads\/2018\/05\/JME_Regional-Classifications.xlsx."},{"key":"e_1_3_7_12_2","volume-title":"Monthly Figures on Total Population","author":"Planning and statistics Authority State of Qatar","year":"2020","unstructured":"Planning and statistics Authority State of Qatar. Monthly Figures on Total Population. Doha: Planning and statistics Authority State of Qatar; 2020."},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-022-02193-4"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-020-00170-6"},{"key":"e_1_3_7_15_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2052-1839-13-9","article-title":"Time-to-Diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the haematological malignancy research network","volume":"13","author":"Howell DA","year":"2013","unstructured":"Howell DA, Smith AG, Jack A, et al. Time-to-Diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the haematological malignancy research network. BMC Hematol. 2013;13:9. https:\/\/www.hmds.info\/.","journal-title":"BMC Hematol"},{"key":"e_1_3_7_16_2","doi-asserted-by":"crossref","first-page":"21615","DOI":"10.1002\/cam4.6696","article-title":"Assessment of 2022 European LeukemiaNet risk classification system in real-world cohort from China","volume":"12","author":"Chen E","year":"2023","unstructured":"Chen E, Jiao C, Yu J, et al. Assessment of 2022 European LeukemiaNet risk classification system in real-world cohort from China. Cancer Med. 2023;12:21615-21626.","journal-title":"Cancer Med"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-027714"},{"key":"e_1_3_7_18_2","unstructured":"American Cancer Society. Information and resources about for cancer. 2023. https:\/\/www.cancer.org\/."},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(22)01331-3"},{"key":"e_1_3_7_20_2","doi-asserted-by":"crossref","unstructured":"De Moraes Hungria VT Chiattone C Pavlovsky M et al. Epidemiology of hematologic malignancies in real-world settings: findings from the hemato-oncology Latin america observational registry study. J Glob Oncol 2019:1\u201319 (2019).","DOI":"10.1200\/JGO.19.00025"},{"key":"e_1_3_7_21_2","doi-asserted-by":"crossref","unstructured":"Dapkevi\u010di\u016bt\u0117 A \u0160apoka V Martynova E Pe\u010deli\u016bnas V. Time from symptom onset to diagnosis and treatment among haematological malignancies: influencing factors and associated negative outcomes. Medicina. 2019;55.","DOI":"10.3390\/medicina55060238"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.10100"},{"key":"e_1_3_7_23_2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4103\/2278-330X.202559","article-title":"Pediatric hematological malignancy: identification of issues involved in the road to diagnosis","volume":"6","author":"Venkatasai JP","year":"2017","unstructured":"Venkatasai JP, Srinivasamaharaj S, Sneha LM, Scott JX, Baby AK, Rajan M. Pediatric hematological malignancy: identification of issues involved in the road to diagnosis. South Asian J Cancer. 2017;6:28-30.","journal-title":"South Asian J Cancer"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127717"},{"key":"e_1_3_7_25_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2020.101837","article-title":"Childhood cancer in Latin America: from detection to palliative care and survivorship","author":"Guzman CPC","year":"2021","unstructured":"Guzman CPC, Cordoba MA, Godoy N, et al. Childhood cancer in Latin America: from detection to palliative care and survivorship. Cancer Epidemiol. 2021;71.","journal-title":"Cancer Epidemiol"},{"key":"e_1_3_7_26_2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10389-021-01517-x","article-title":"Time to diagnosis of pediatric cancer and factors that require attention","volume":"31","author":"Ribeiro ILA","year":"2023","unstructured":"Ribeiro ILA, de Melo ACR, Santiago BM, et al. Time to diagnosis of pediatric cancer and factors that require attention. J Public Health. 2023;31:397-404.","journal-title":"J Public Health"},{"key":"e_1_3_7_27_2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/MPH.0000000000002344","article-title":"Longer time intervals from symptom onset to diagnosis affect the overall survival in children with acute lymphoblastic leukemia","volume":"44","author":"Dai Q","year":"2022","unstructured":"Dai Q, Liu R, Wang Y, et al. Longer time intervals from symptom onset to diagnosis affect the overall survival in children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2022;44:285-292.","journal-title":"J Pediatr Hematol Oncol"},{"key":"e_1_3_7_28_2","doi-asserted-by":"crossref","first-page":"e2200131","DOI":"10.1200\/GO.22.00131","article-title":"A ten-year experience of treating chronic myeloid leukemia in rural Rwanda: outcomes and insights for a changing landscape","volume":"8","author":"Morgan J","year":"2022","unstructured":"Morgan J, DeBoer RJ, Bigirimana JB, et al. A ten-year experience of treating chronic myeloid leukemia in rural Rwanda: outcomes and insights for a changing landscape. JCO Glob Oncol. 2022;8:e2200131. https:\/\/ascopubs.org\/go\/authors\/open-access.","journal-title":"JCO Glob Oncol"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1732853"},{"key":"e_1_3_7_30_2","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1097\/MPH.0b013e3182580bea","article-title":"Delayed diagnosis of leukemia and association with morbid-mortality in children in Pernambuco, Brazil","volume":"34","author":"Lins MM","year":"2012","unstructured":"Lins MM, Amorim M, Vilela P, et al. Delayed diagnosis of leukemia and association with morbid-mortality in children in Pernambuco, Brazil. J Pediatr Hematol Oncol. 2012;34:e271-e276.","journal-title":"J Pediatr Hematol Oncol"},{"key":"e_1_3_7_31_2","doi-asserted-by":"crossref","DOI":"10.2196\/36490","article-title":"A review of artificial intelligence applications in hematology management: current practices and future prospects","volume":"24","author":"El Alaoui Y","year":"2022","unstructured":"El Alaoui Y, Elomri A, Qaraqe M, et al. A review of artificial intelligence applications in hematology management: current practices and future prospects. J Med Internet Res. 2022;24:e36490.","journal-title":"J Med Internet Res"},{"key":"e_1_3_7_32_2","unstructured":"https:\/\/gco.iarc.fr\/today. https:\/\/gco.iarc.fr\/today\/online-analysis-map?v=2020&mode=population&mode_population=continents&population=900&populations=900&key=asr&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=10&group_cancer=1&include_nmsc=0&include_nmsc_other=0&projection=natural-earth&color_palette=default&map_scale=quantile&map_nb_colors=5&continent=0&show_ranking=0&rotate=%255B10%252C0%255D."},{"key":"e_1_3_7_33_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192416952"},{"key":"e_1_3_7_34_2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1126\/science.abb9601","article-title":"Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention","volume":"369","author":"Lennon AM","year":"2020","unstructured":"Lennon AM, Buchanan AH, Kinde I, et al. Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention. Science. 2020;369:369.","journal-title":"Science"},{"key":"e_1_3_7_35_2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/bjc.2013.791","article-title":"Comparison of cancer diagnostic intervals before and after implementation of NICE guidelines: analysis of data from the UK General Practice Research Database","volume":"110","author":"Neal RD","year":"2014","unstructured":"Neal RD, Din NU, Hamilton W, et al. Comparison of cancer diagnostic intervals before and after implementation of NICE guidelines: analysis of data from the UK General Practice Research Database. Br J Cancer. 2014;110:584-592.","journal-title":"Br J Cancer"},{"key":"e_1_3_7_36_2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11845-016-1460-4","article-title":"Audit of compliance with the British Committee for Standards in Haematology (BCSH) revised guidelines for the diagnosis and assessment of treatment response of hairy cell leukemia in University Hospital Galway","volume":"186","author":"Velazquez-Kennedy K","year":"2017","unstructured":"Velazquez-Kennedy K, Crowe C, Craven B, Walsh J, Prendergast C, Krawczyk J. Audit of compliance with the British Committee for Standards in Haematology (BCSH) revised guidelines for the diagnosis and assessment of treatment response of hairy cell leukemia in University Hospital Galway. Ir J Med Sci. 2017;186:345-347.","journal-title":"Ir J Med Sci"},{"key":"e_1_3_7_37_2","doi-asserted-by":"publisher","DOI":"10.3399\/BJGP.2020.1030"},{"key":"e_1_3_7_38_2","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.7314\/APJCP.2016.17.3.1019","article-title":"Proactive consultation by a clinical pathologist prevents diagnostic delay in hematological malignancies","volume":"17","author":"Chang CC","year":"2016","unstructured":"Chang CC, Su MJ, Ho JL, et al. Proactive consultation by a clinical pathologist prevents diagnostic delay in hematological malignancies. Asian Pac J Cancer Prev APJCP. 2016;17:1019-1022.","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"e_1_3_7_39_2","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp17X694169"},{"key":"e_1_3_7_40_2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fonc.2018.00187","article-title":"A step toward timely referral and early diagnosis of cancer: implementation and impact on knowledge of a primary care-based training program in Botswana","volume":"8","author":"Tapela NM","year":"2018","unstructured":"Tapela NM, Peluso MJ, Kohler RE, et al. A step toward timely referral and early diagnosis of cancer: implementation and impact on knowledge of a primary care-based training program in Botswana. Front Oncol. 2018;8:187.","journal-title":"Front Oncol"},{"key":"e_1_3_7_41_2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s12885-015-1424-5","article-title":"The Danish cancer pathway for patients with serious non-specific symptoms and signs of cancer-a cross-sectional study of patient characteristics and cancer probability","volume":"15","author":"Ingeman ML","year":"2015","unstructured":"Ingeman ML, Christensen MB, Bro F, Knudsen ST, Vedsted P. The Danish cancer pathway for patients with serious non-specific symptoms and signs of cancer-a cross-sectional study of patient characteristics and cancer probability. BMC Cancer. 2015;15:421.","journal-title":"BMC Cancer"},{"key":"e_1_3_7_42_2","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp12X654551"}],"container-title":["Cancer Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10732748241275026","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10732748241275026","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10732748241275026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:23:22Z","timestamp":1777386202000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10732748241275026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":41,"alternative-id":["10.1177\/10732748241275026"],"URL":"https:\/\/doi.org\/10.1177\/10732748241275026","relation":{},"ISSN":["1073-2748","1526-2359"],"issn-type":[{"value":"1073-2748","type":"print"},{"value":"1526-2359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"article-number":"10732748241275026"}}